Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-541468 in Subjects With Hepatic Impairment
NCT03713242Phase 1Completed
- Sponsor
- Idorsia
- Start
- Feb 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of daridorexant in Insomnia, sponsored by Idorsia. Started Feb 2018; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03713242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03713242.